In rats that had a heart attack, a drug called dapagliflozin helped them live longer and made their hearts pump better, according to ultrasound scans.

A diabetes drug called dapagliflozin may help protect the hearts of diabetic rats and mice after a heart attack by making them pee out more sugar and easing the strain on their hearts.

After a heart attack in rats, a diabetes drug called dapagliflozin seems to calm down the heart’s inflammation by reducing harmful immune cells and chemicals, while boosting a helpful one that soothes the damage.

In mice with heart damage from interrupted blood flow, a diabetes drug called dapagliflozin helps calm down inflammation in tiny blood vessels and stops heart cells from dying too soon.

A diabetes drug called dapagliflozin may help protect heart blood vessel cells from damage after a heart attack by stopping certain harmful chemical signals, which keeps the cells’ internal structure intact and prevents them from dying.

A diabetes drug called dapagliflozin may help protect heart blood vessels from damage caused by temporary lack of oxygen and then sudden return of blood flow, by calming down a harmful enzyme, keeping a key protein from getting damaged, and helping cells manage calcium properly — which keeps the vessel lining intact and stops cells from dying.